Zydus Lifesciences informs about press release

31 Jul 2024 Evaluate
Zydus Lifesciences has enclosed a copy of press release dated July 31, 2024 titled ‘Zydus receives approval from COFEPRIS of Mexico to market Mamitra (Trastuzumab biosimilar) to treat various cancers’. The contents of the press release give full details. 

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

916.55 -5.45 (-0.59%)
12-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1825.00
Dr. Reddys Lab 1318.75
Cipla 1325.25
Zydus Lifesciences 916.55
Lupin 2356.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×